Melanoma and Immune Checkpoint Inhibitors
Sign Up to like & getrecommendations! Published in 2018 at "Current Oncology Reports"
DOI: 10.1007/s11912-018-0676-z
Abstract: Purpose of ReviewPrognosis of patients with advanced melanoma is dismal with a median overall survival of about 8 months and 5-year overall survival from a diagnosis of metastatic disease of roughly 10%. However, immune checkpoint inhibitors… read more here.
Keywords: immune checkpoint; checkpoint inhibitors; melanoma immune; inhibitors melanoma ... See more keywords